Study on Standard Evaluation System and Optimal Treatment Path of Senile Valvular Heart Disease

  • STATUS
    Recruiting
  • participants needed
    6000
  • sponsor
    Yongjian Wu
Updated on 15 September 2021
heart disease
stenosis
regurgitation
valvular disease
mitral stenosis
aortic stenosis

Summary

The key technology research and standard evaluation system of elderly heart valve disease evaluation is to further establish a domestic multi center and large sample full information big data platform of elderly heart valve disease based on the previous Chinese elderly valve disease cohort and clinical research platform and the national valve disease surgery data platform.

Description

Establish clinical and Imaging Database

Details
Condition Heart Disease, Heart disease, VALVULAR HEART DISEASE, Heart Valve Disease
Age 65years - 100years
Treatment imaging
Clinical Study IdentifierNCT05044338
SponsorYongjian Wu
Last Modified on15 September 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

(1) Inclusion criteria: Patients with heart valve disease who are 65 years old and diagnosed by echocardiography meet the requirements
One of the following criteria
Severe mitral stenosis: valve orifice area < 1.0cm2; Severe mitral
regurgitation: constriction neck width 7mm, or regurgitation per beat
(regurgitation volume) 60ml, or reflux beam area / left atrial area > 50%; Or
effective reflux port area (eroa) 0.4cm2; Severe aortic stenosis: mean cross
valve pressure difference 40mmhg, or maximum jet velocity 4m / s, orValve
orifice area < 1.0cm2, it should be differentiated from left ventricular
outflow tract stenosis; Severe aortic regurgitation: constriction neck width >
mm, or each pulsation regurgitation 60ml, or regurgitation Flow fraction 50%
or jet width 65% of left ventricular outflow tract, or effective reflux
orifice area (eroa) 0.3cm2 Severe tricuspid stenosis: mean cross valve
pressure difference 5mmhg; Severe tricuspid regurgitation: constriction neck
width 7mm, or effective regurgitation orifice area (eroa)0.4cm2 Severe
pulmonary stenosis: the forward blood flow velocity is 4m / s, which should be
differentiated from right ventricular outflow tract stenosis; Severe pulmonary
valve regurgitation: massive regurgitation, wide constriction neck

Exclusion Criteria

Patients unwilling to accept registration and follow-up; Patients with mental illness who cannot cooperate with information collection and follow-up
Clear my responses

How to participate?

Step 1 Connect with a study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.